Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Saigal

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
BMC Urology|November 7, 2006
Prevalence and trends of selected urologic conditions for VA healthcare usersMin-Woong Sohn, Huiyuan Zhang, Brent C Taylor, et al.
Urology|April 16, 2016
Questioning the 10-year Life Expectancy Rule for High-grade Prostate Cancer: Comparative Effectiveness of Aggressive vs Nonaggressive Treatment of High-grade Disease in Older Men With Differing Comorbid Disease BurdensTimothy J Daskivich, Julie Lai, Andrew W Dick, et al.
Cancer|July 22, 2014
Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancerTimothy J Daskivich, Julie Lai, Andrew W Dick, et al.
The Journal of Urology|May 18, 2011
Practice variation in the surgical management of urinary lithiasisCharles D Scales, Tracey L Krupski, Lesley H Curtis, et al.
JCO Clinical Cancer Informatics|January 19, 2019
Use of the Electronic Medical Record to Facilitate Intervention for Patients With Rising Prostate-Specific Antigen Values After Radical Prostatectomy: A Feasibility StudyAmar U Kishan, Eric M Cheng, Eric Schmidt, et al.
American Journal of Clinical Oncology|August 26, 2016
Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer?Amar U Kishan, Gillian Duchesne, Pin-Chieh Wang, et al.
BMJ Surgery, Interventions, & Health Technologies|August 30, 2021
Perceptions of partial gland ablation for prostate cancer among men on active surveillance: A qualitative studySonia S Hur, Michael Tzeng, Eliza Cricco-Lizza, et al.
Neurosurgical Focus|November 4, 2014
Time-driven activity-based costing: a driver for provider engagement in costing activities and redesign initiativesNancy McLaughlin, Michael A Burke, Nisheeta P Setlur, et al.
Urology|September 1, 2021
Trends in the Racial and Ethnic Diversity in the US Urology WorkforceEfe Chantal Ghanney Simons, Aileen Arevalo, Samuel L Washington, et al.
American Journal of Clinical Oncology|March 17, 2017
Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate CancerAmar U Kishan, Gillian Duchesne, Pin-Chieh Wang, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
BMC Urology|November 7, 2006
Prevalence and trends of selected urologic conditions for VA healthcare usersMin-Woong Sohn, Huiyuan Zhang, Brent C Taylor, et al.
Urology|April 16, 2016
Questioning the 10-year Life Expectancy Rule for High-grade Prostate Cancer: Comparative Effectiveness of Aggressive vs Nonaggressive Treatment of High-grade Disease in Older Men With Differing Comorbid Disease BurdensTimothy J Daskivich, Julie Lai, Andrew W Dick, et al.
Cancer|July 22, 2014
Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancerTimothy J Daskivich, Julie Lai, Andrew W Dick, et al.
The Journal of Urology|May 18, 2011
Practice variation in the surgical management of urinary lithiasisCharles D Scales, Tracey L Krupski, Lesley H Curtis, et al.
JCO Clinical Cancer Informatics|January 19, 2019
Use of the Electronic Medical Record to Facilitate Intervention for Patients With Rising Prostate-Specific Antigen Values After Radical Prostatectomy: A Feasibility StudyAmar U Kishan, Eric M Cheng, Eric Schmidt, et al.
American Journal of Clinical Oncology|August 26, 2016
Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer?Amar U Kishan, Gillian Duchesne, Pin-Chieh Wang, et al.
BMJ Surgery, Interventions, & Health Technologies|August 30, 2021
Perceptions of partial gland ablation for prostate cancer among men on active surveillance: A qualitative studySonia S Hur, Michael Tzeng, Eliza Cricco-Lizza, et al.
Neurosurgical Focus|November 4, 2014
Time-driven activity-based costing: a driver for provider engagement in costing activities and redesign initiativesNancy McLaughlin, Michael A Burke, Nisheeta P Setlur, et al.
Urology|September 1, 2021
Trends in the Racial and Ethnic Diversity in the US Urology WorkforceEfe Chantal Ghanney Simons, Aileen Arevalo, Samuel L Washington, et al.
American Journal of Clinical Oncology|March 17, 2017
Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate CancerAmar U Kishan, Gillian Duchesne, Pin-Chieh Wang, et al.
Pageof 4